Patients with type 2 diabetes and inflammatory arthritis who received GLP-1 RAs had lower rates of hypoglycemia, serious infections, and acute kidney injury vs those receiving SGLT2 inhibitors.

Researchers compared the incidence of infection-related outcomes and hypoglycemia across antidiabetic drug classes in patients with inflammatory arthritis and diabetes. Patients with type 2 diabetes ...

GLP-1 RA use was associated with improved cardiometabolic outcomes without significantly affecting mental health outcomes among pediatric patients. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs ...

D-Wave Quantum stock (NYSE: QBTS) has skyrocketed by an impressive 2,200% over the past twelve months. What is the reason behind this? It has been an ideal blend of excitement and momentum. Firstly, ...

GLP-1 RAs show greater cardiovascular benefits in type 2 diabetes patients with BMI ≥25 compared to DPP-4 inhibitors. Kidney protection from GLP-1 RAs remains consistent across all BMI categories. The ...

When used as first-line therapy in patients with type 2 diabetes (T2D), GLP-1 receptor agonists (RAs) seemed to be more effective than metformin at reducing the risk for dementia, particularly ...

JWST observations of exoplanet TRAPPIST-1d reveal a lack of a substantial, Earth-like atmosphere, as indicated by a "flat" spectral signature lacking typical atmospheric molecule fingerprints (e.g., ...

GLP-1 RA use had positive effects on intracranial hypertension management, including reduced symptoms and treatment burden. Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with ...

HEC Infra Projects Limited, a prominent firm in the infrastructure sector, has announced its unaudited financial outcomes for the first quarter of the fiscal year 2026. According to the results ...

GLP-1 RAs do not increase risk for acute pancreatitis among individuals with type 2 diabetes. Treatment with GLP-1 receptor agonists (GLP-1 RAs) among patients with type 2 diabetes (T2D) does not ...